Skip to main content

Advertisement

Figure 2 | BMC Cancer

Figure 2

From: Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients

Figure 2

Immunohistochemical analysis of EpEx expression in breast cancer. Expression of EpEx in (I) normal breast tissues; (II) DCIS; (III) IDC; (IV) ILC; (V) IMC; (VI) negative control breast cancer tissue incubated with isotype specific IgG showing no detectable immunostaining for EpEX. Membranous EpEx expression was more frequently observed in breast carcinomas compared to normal tissues, except ILC (original magnification × 400). The arrows labelled M depict membrane staining.

Back to article page